Researchers have developed a novel tablet formulation of ibandronate which increases the oral bioavailability of the drug by releasing it from a hydrogel raft formed in the stomach.
On the afternoon of 17 February, the State Council inter-agency task force on responding to the novel coronavirus pneumonia (NCP, or COVID-19) outbreak held a press briefing on the latest progress in medical treatment of NCP cases.